Similar articles for PMID: 25342385

Year	Number of Results
1963	1
1964	1
1981	1
1987	1
1989	1
1990	1
1992	1
1993	3
1996	1
1997	4
2000	1
2001	4
2002	7
2003	9
2004	8
2005	9
2006	3
2007	5
2008	6
2009	12
2010	5
2011	7
2012	11
2013	14
2014	19
2015	24
2016	27
2017	37
2018	32
2019	28
2020	27
2021	25
2022	21
2023	10
2024	0

1

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.

Vallabhajosula S, Nikolopoulou A, Babich JW, Osborne JR, Tagawa ST, Lipai I, Solnes L, Maresca KP, Armor T, Joyal JL, Crummet R, Stubbs JB, Goldsmith SJ. Vallabhajosula S, et al. J Nucl Med. 2014 Nov;55(11):1791-8. doi: 10.2967/jnumed.114.140426. Epub 2014 Oct 23. J Nucl Med. 2014. PMID: 25342385 Free article. Clinical Trial.

2

99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.

Hillier SM, Maresca KP, Lu G, Merkin RD, Marquis JC, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW. Hillier SM, et al. J Nucl Med. 2013 Aug;54(8):1369-76. doi: 10.2967/jnumed.112.116624. Epub 2013 Jun 3. J Nucl Med. 2013. PMID: 23733925 Free article.

3

Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.

Robu S, Schottelius M, Eiber M, Maurer T, Gschwend J, Schwaiger M, Wester HJ. Robu S, et al. J Nucl Med. 2017 Feb;58(2):235-242. doi: 10.2967/jnumed.116.178939. Epub 2016 Sep 15. J Nucl Med. 2017. PMID: 27635024 Free article.

4

PSMA SPECT/CT with ^99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels.

Schmidkonz C, Goetz TI, Kuwert T, Ritt P, Prante O, Bäuerle T, Goebell P, Cordes M. Schmidkonz C, et al. Ann Nucl Med. 2019 Dec;33(12):891-898. doi: 10.1007/s12149-019-01400-6. Epub 2019 Sep 9. Ann Nucl Med. 2019. PMID: 31502084

5

Preparation and Biological Evaluation of [^99mTc]Tc-CNGU as a PSMA-Targeted Radiotracer for the Imaging of Prostate Cancer.

Xiao D, Duan X, Gan Q, Zhang X, Zhang J. Xiao D, et al. Molecules. 2020 Nov 26;25(23):5548. doi: 10.3390/molecules25235548. Molecules. 2020. PMID: 33256058 Free PMC article.

6

Intraindividual Comparison of ^99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand ^99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.

Rathke H, Afshar-Oromieh A, Giesel FL, Kremer C, Flechsig P, Haufe S, Mier W, Holland-Letz T, De Bucourt M, Armor T, Babich JW, Haberkorn U, Kratochwil C. Rathke H, et al. J Nucl Med. 2018 Sep;59(9):1373-1379. doi: 10.2967/jnumed.117.200220. Epub 2018 Jan 25. J Nucl Med. 2018. PMID: 29371410 Free article.

7

SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer.

Schmidkonz C, Cordes M, Beck M, Goetz TI, Schmidt D, Prante O, Bäuerle T, Uder M, Wullich B, Goebell P, Kuwert T, Ritt P. Schmidkonz C, et al. Clin Nucl Med. 2018 Apr;43(4):225-231. doi: 10.1097/RLU.0000000000001991. Clin Nucl Med. 2018. PMID: 29401151

8

^99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer.

Schmidkonz C, Hollweg C, Beck M, Reinfelder J, Goetz TI, Sanders JC, Schmidt D, Prante O, Bäuerle T, Cavallaro A, Uder M, Wullich B, Goebell P, Kuwert T, Ritt P. Schmidkonz C, et al. Prostate. 2018 Jan;78(1):54-63. doi: 10.1002/pros.23444. Epub 2017 Nov 6. Prostate. 2018. PMID: 29105797

9

Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy.

Zechmann CM, Afshar-Oromieh A, Armor T, Stubbs JB, Mier W, Hadaschik B, Joyal J, Kopka K, Debus J, Babich JW, Haberkorn U. Zechmann CM, et al. Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1280-92. doi: 10.1007/s00259-014-2713-y. Epub 2014 Feb 28. Eur J Nucl Med Mol Imaging. 2014. PMID: 24577951 Free PMC article.

10

Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA).

Ray Banerjee S, Pullambhatla M, Foss CA, Falk A, Byun Y, Nimmagadda S, Mease RC, Pomper MG. Ray Banerjee S, et al. J Med Chem. 2013 Aug 8;56(15):6108-21. doi: 10.1021/jm400823w. Epub 2013 Jul 22. J Med Chem. 2013. PMID: 23799782 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

316 results

Results by year